A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma

Name: A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
License: Public Domain

Seagen Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, large-cell, anaplastic, lymphoma, non-hodgkin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 140976
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.